CK2/PIM1-IN-1 is an inhibitor of CK2 and PIM1, with IC50s of 3.787 μM and 4.327 μM for CK2 and PIM1, respectively. CK2/PIM1-IN-1 is developed for the research of proliferative disorders such as cancer, as well as other kinase-associated conditions including inflammation, pain, vascular disorders, pathogenic infections and certain immunological disorders. References: [1]. Mustapha Haddach, et al. Rhodanines and related heterocycles as kinase inhibitors. WO2010148351A1.

纯度：≥98%

CAS：292640-28-9